Rezolute (RZLT) Enterprise Value Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rezolute | 374.41 Mn | 374.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.36% |
| Dec 31, 2025 | -37.71% |
| Sep 30, 2025 | -40.57% |
| Jun 30, 2025 | -32.30% |
| Mar 31, 2025 | -8.63% |
| Dec 31, 2024 | -4.21% |
| Sep 30, 2024 | -9.59% |
| Jun 30, 2024 | -24.51% |
| Mar 31, 2024 | 22.38% |
| Dec 31, 2023 | 36.90% |
| Sep 30, 2023 | 35.98% |
| Jun 30, 2023 | 32.25% |
| Mar 31, 2023 | -62.52% |
| Dec 31, 2022 | -89.59% |
| Sep 30, 2022 | -313.73% |
| Jun 30, 2022 | -266.43% |
| Mar 31, 2022 | -98.24% |
| Dec 31, 2021 | -105.85% |
| Sep 30, 2021 | -482.45% |
| Jun 30, 2021 | 46.97% |
| Mar 31, 2021 | -127.96% |
| Dec 31, 2020 | -106.80% |
| Sep 30, 2020 | 71.03% |
| Jun 30, 2020 | -105.86% |
| Mar 31, 2020 | 8.54% |
| Dec 31, 2019 | -6,947.29% |
| Sep 30, 2019 | -5,412.22% |
| Jun 30, 2019 | -2,184.33% |
| Mar 31, 2012 | 82.88% |
| Dec 31, 2011 | 60.92% |
| Sep 30, 2011 | -682.60% |